Indoco Remedies Ltd share price logo

Indoco Remedies Share Price (INDOCO)

Check the latest share price of Indoco Remedies, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹250.68

1.04%

as on 04:01PM, 30 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Indoco Remedies Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹247
    Day's Price Range
    ₹253.31
  • 52 Week's Low

    52 Week's High

    ₹190
    52-Week Price Range
    ₹387.55
1 Month Return+ 9.15 %
3 Month Return+ 11.73 %
1 Year Return-16.57 %
3 Year Return-29.02 %
5 Year Return+ 20.43 %
Previous Close₹253.31
Open₹253.31
Volume36.38K
Upper Circuit₹303.97
Lower Circuit₹202.64

Indoco Remedies Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹2,312.47 Cr

Return on Equity (ROE)

10.83

PE Ratio (TTM)

-29.67

Return on capital employed (ROCE)

12.31

Industry PE ratio

56.12

Beta (LTM)

0

P/B Ratio

2.69

Dividend Yield

0.46

PEG Ratio

1.56

Quarterly Earnings Growth YOY

-287.65

EPS (TTM)

10.52

Sector

Pharmaceuticals

Book Value

120.4

Technical Analysis

How to invest in Indoco Remedies?

Investing in Indoco Remedies is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Indoco Remedies or INDOCO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Indoco Remedies or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Indoco Remedies with just a few clicks!

Indoco Remedies Stock's Interest Amongst Investors

59%

Period May 31, 2025 to May 01, 2025. Change in 30 Days vs previous period

Search interest for Indoco Remedies Ltd Stock has increased by 59% in the last 30 days, reflecting an upward trend in search activity.

Indoco Remedies Valuation

Track how the P/E of Indoco Remedies has moved over time to understand valuation trends.

Indoco Remedies in the last 5 years

  • Overview

  • Trends

Lowest (-705.32x)

April 24, 2019

Today (-29.67x)

May 30, 2025

Industry (56.12x)

May 30, 2025

Highest (242.71x)

September 6, 2018

LowHigh

Today’s Price to Earnings Ratio: -29.67x

Analysts Recommendation on Indoco Remedies

Get updated buy, sell, and hold recommendations by analysts on Indoco Remedies.

based on 5 analysts

SELL

0.00%

Buy

60.00%

Hold

40.00%

Sell

60% of analysts recommend a 'SELL' rating for Indoco Remedies. Average target price of ₹260.4

Source: S&P Global Market Intelligence

Analysts Forecast on Indoco Remedies

Get share price movements and forecasts by analysts on Indoco Remedies.

Indoco Remedies price forecast by 5 analysts

Upside of3.88%

High

₹325

Target

₹260.40

Low

₹200

Indoco Remedies target price ₹260.4, a slight upside of 3.88% compared to current price of ₹250.68. According to 5 analysts rating.

Source: S&P Global Market Intelligence

Indoco Remedies Financials

Get the annual and quarterly financial summary of Indoco Remedies, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

439 (0%)424 (3%)431 (2%)402 (7%)384 (5%)
Net Income

(in ₹ Cr)

22 (0%)2 (92%)-10 (650%)-28 (184%)-41 (46%)
Net Profit Margin5.02% (0%)0.43% (91%)-2.32% (640%)-7.06% (204%)-10.77% (53%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

1359 (0%)1517 (12%)1686 (11%)1987 (18%)
Total Liabilities

(in ₹ Cr)

590 (0%)613 (4%)659 (7%)860 (31%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

123 (0%)82 (33%)174 (111%)179 (3%)177 (1%)

Indoco Remedies Index Inclusions

BSE Healthcare

₹42,604.29

-0.26 (-110.81%)

BSE Small-Cap

₹52,413.25

0.17 (87.5%)

Indoco Remedies Earnings and Dividends

View detailed summary of the earnings and dividend history of Indoco Remedies.

  • Indoco Remedies Ltd Earnings Results

    Indoco Remedies Ltd’s net profit fell -277.93% since last year same period to ₹-40.39Cr in the Q4 2024-2025. On a quarterly growth basis, Indoco Remedies Ltd has generated -53.05% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Indoco Remedies Ltd Dividends May,2024

    In the quarter ending March 2024, Indoco Remedies Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.50%.

    Read More about Dividends

Indoco Remedies Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Indoco Remedies.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
58.9%
0.00
Foreign Institutions
1.24%
0.00
Mutual Funds
18.52%
0.00
Retail Investors
21.02%
0.00
Others
0.32%
0.00

Indoco Remedies vs Peers

Compare market cap, revenue, PE, and other key metrics of Indoco Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
SELL2,312.474.09%0.67NANA
BUY26,670.77114.11%0.52NANA
BUY18,698.6338.27%0.57NANA
NA6,008.526.86%0.79NANA
BUY14,242.6242.31%0.68NANA

Indoco Remedies News & Key Events

Latest news and events at one place to help you take investing decisions in Indoco Remedies.

  • Indoco Remedies Reports Decline in Sales and Losses - 27 May, 2025

    Indoco Remedies reported a 13.22% decline in consolidated net sales to Rs 390.21 crore for March 2025, with a net loss of Rs 40.39 crore. EBITDA also fell significantly by 97.59%. The stock has seen negative returns of -23.30% over the last 6 months and -23.89% over the last year.
  • Indoco Remedies Gains from USFDA Approval News - 23 May, 2025

    Indoco Remedies shares rose after the company received final USFDA approval for Allopurinol tablets, a generic equivalent to Zyloprim. Despite a reported net loss, the approval positively impacted investor sentiment.
  • Indoco Remedies Reports Loss, Shares Decline - 22 May, 2025

    Indoco Remedies reported a significant decline in Q4 results, with net sales down 22.05% YoY and a net loss of Rs. 26.24 crore. Following the announcement, shares fell 7%, reflecting investor concerns.

Insights on Indoco Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 58.80% to 58.90% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 18.21% to 18.52% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.3% return, outperforming this stock by 68.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 119.1% return, outperforming this stock by 147.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, 22.7 Cr → -40.39 Cr (in ₹), with an average decrease of 195.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 434.22 Cr → 392.23 Cr (in ₹), with an average decrease of 5.0% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.25% to 1.24% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.03% to 21.02% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, INDOCO stock has moved down by -28.0%

About Indoco Remedies

Indoco Remedies Limited is a Mumbaibased pharmaceutical company established in 1947 and currently has a presence in 55 countries with a USD 166 million turnover. It mainly focuses on Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients. It is presently active in therapeutic segments, including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and antifungal. It has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, and is supported by a state-of-the-art RD Centre. AC Nielsen ORGMARG market survey ranks Indoco first in stomatology, ninth in opthalmic and 12th in pediatric segments in terms of prescription generation. It has a marketing network of 1248 medical representatives. To further its goals, the company purchased remaining shares of Xtend Industrial Designers and Engineers in 2014, and acquired a Clinical Research Division from Piramal Enterprise in 2015. It likewise incorporated Indoco Remedies Singapore Pte Limited in 2015 and established a 100% subsidiary in Czech Republic in 2019. It has also launched 8 new products, 5 in Cardiac, 2 in Anti-diabetic and 1 in Dermatology. The company is further patent-recognised for products like Olopatadine, Gliclazide, Brinzolamide, Febuxostat, Rufinamide, Lacosamide, Tapentadol, Aminoindane compound and Pyrazole derivatives. It currently has 3 subsidiary companies under its fold, Xtend Industrial Designers and Engineers Pvt. Ltd., Indoco Remedies Czech sro and Indoco Remedies UK Limited.

Revenue: ₹383.89Cr as on March 2025 (Q4 FY25)
Net Profit: ₹-41.34Cr as on March 2025 (Q4 FY25)
Listing date: 14 Jan, 2005
Chairperson Name: Suresh G Kare
OrganisationIndoco Remedies Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSuresh G Kare
E-voting on sharesClick here to vote

Indian Mutual Funds that own Indoco Remedies

Check out the Mutual Funds with significant holdings in Indoco Remedies.

FAQs

What is Indoco Remedies share price today?

Indoco Remedies share price today stands at ₹250.68, Open: ₹253.31, Previous Close: ₹253.31, High: ₹253.31, Low: ₹247, 52 Week High: ₹387.55, 52 Week Low: ₹190.

What is today's traded volume of Indoco Remedies?

Today's traded volume of Indoco Remedies is 36.38K. Which means that 36.38K shares of Indoco Remedies were bought and sold on the stock market during today's trading session.

What is Indoco Remedies's market cap today?

Today's market capitalisation of Indoco Remedies is ₹2,312.47 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Indoco Remedies?

Indoco Remedies’s 52 week high is ₹387.55 and 52 week low is ₹190. The current share price of Indoco Remedies is ₹250.68, which is -35.32% down from its 52 week high and 31.94% up from its 52 week low.